Le Blog de Ben-Ari

Publications & News

Menu Skip to content

Blog Posts
Career
Scientific publications
Conférence
- Participation
- Organisation
Press release
Photos
Useful links

Conferences

Like this:

Like Loading...

Yehezkel Ben-Ari

C.E.O of Neurochlore & B&A Therapeutics Founder and first Director of Institut de Neurobiologie de la Méditerranée Curiculum Vitae

Follow me

View Benari_Y’s profile on Twitter
View yehezkel-ben-ari-376349120?trk=hp-identity-name’s profile on LinkedIn

Contact

Neurochlore
Batiment Beret-Delaage, Zone Luminy Biotech, Case 922
13288 Marseille cedex 09

Contact

Curiculum Vitae

TEDxCanebière – Brain development theory to treat autism (subtitled)

Recently published papers

The GABA Developmental Shift Is Abolished by Maternal Immune Activation Already at Birth
Cerebral Cortex, November 3rd 2018

Maturation of GABAergic Transmission in Cerebellar Purkinje Cells Is Sex Dependent and Altered in the Valproate Model of Autism
Frontiers in Cellular Neuroscience, July 30th 2018

Striatal dual cholinergic/GABAergic transmission in Parkinson disease : friends or foes?
Cell stress, May 27th 2018

Term or Preterm Cesarean Section Delivery Does Not Lead to Long-term Detrimental Consequences in Mice
Cerebral Cortex, May 16th 2018

GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease, Nature Communications, April 12th 2018

Bumetanide for autism: more eye contact, less amygdala activation, Scientific Reports, February 26th 2018

On sale in bookstore

Authors : Yehezkel Ben-Ari, Eric Lemonnier, Nouchine Hadjikhani. Edited by de boeck

upcoming conferences

No upcoming events

My Tweets

Create a free website or blog at WordPress.com.

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

%d bloggers like this:

Partager :

Like this: